9.43

0.95% -0.09

After Hours: 9.3525 -0.0775 -0.82%

Mind Medicine Inc (MNMD)

Overview News Price History Option Chain Discussions Forecast Stock Split

Mind Medicine Inc stock is currently priced at $9.43, with a 24-hour trading volume of 1.29M. It has seen a -0.95% decreased in the last 24 hours and a -0.95% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $9.29 pivot point. If it approaches the $9.78 resistance level, significant changes may occur.

Previous Close:

$9.52

Open:

$9.43

24h Volume:

1.29M

Market Cap:

$677.76M

Revenue:

$11.40B

Net Income/Loss:

$-95.73M

P/E Ratio:

-4.7387

EPS:

-1.99

Net Cash Flow:

$-64.37M

1W Performance:

+11.47%

1M Performance:

-0.95%

6M Performance:

+278.71%

1Y Performance:

+146.21%

1D Range:

$9.132

$9.69

52W Range:

$2.41

$12.22

Mind Medicine Inc Stock (MNMD) Company Profile

Name

Mind Medicine Inc

Sector

Healthcare (1189)

Industry

Biotechnology (685)

Phone

Address

One World Trade Center, Suite 8500, New York

Employee

Twitter

Next Earnings Date

2024-05-02

Latest SEC Filings

MNMD's Discussions on Twitter

Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-09-22	Resumed	ROTH Capital	Buy
Nov-16-22	Initiated	RBC Capital Mkts	Outperform
Aug-26-22	Initiated	Oppenheimer	Outperform
Aug-10-22	Initiated	Cantor Fitzgerald	Overweight
May-04-22	Initiated	ROTH Capital	Buy
Jun-28-21	Initiated	Maxim Group	Buy

View All

Mind Medicine Inc Stock (MNMD) Latest News

This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher

The Motley Fool

MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why

Zacks Investment Research

Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session

Benzinga

Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag

Zacks Investment Research

Mind Medicine Inc Stock (MNMD) Financials Data

Mind Medicine Inc (MNMD) Revenue 2024

MNMD reported a revenue (TTM) of $11.40 billion for the quarter ending December 31, 2023, a +3.49% rise year-over-year.

Mind Medicine Inc (MNMD) Net Income 2024

MNMD net income (TTM) was -$95.73 million for the quarter ending December 31, 2023, a -68.55% decrease year-over-year.

Mind Medicine Inc (MNMD) Cash Flow 2024

MNMD recorded a free cash flow (TTM) of -$64.36 million for the quarter ending December 31, 2023, a -28.37% decrease year-over-year.

Mind Medicine Inc (MNMD) Earnings per Share 2024

MNMD earnings per share (TTM) was -$2.45 for the quarter ending December 31, 2023, a -33.15% decline year-over-year.

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.